Evidence map›Paper›PMID 40681800›Full record

ArticleApoptosis : an international journal on programmed cell death2025

Microplastics promote chemoresistance by mediating lipid metabolism and suppressing pyroptosis in colorectal cancer.

Dongzhi Hu, Hui Liu, Yaoyang Guo, Haiyang Zhang, Minghan Qiu, Zhen Yang, Jie Hao, Zhansheng Jiang, Ming Gao, Xipeng Zhang and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Apoptosis : an international journal on programmed cell death, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Dongzhi Hu *Tianjin Institute of Coloproctology, Tianjin Union Medical Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300121, China.
Hui Liu *Tianjin Institute of Coloproctology, Tianjin Union Medical Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300121, China.
Yaoyang Guo *Tianjin Institute of Coloproctology, Tianjin Union Medical Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300121, China.
Haiyang Zhang *Tianjin Institute of Coloproctology, Tianjin Union Medical Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300121, China.
Minghan QiuTianjin Institute of Coloproctology, Tianjin Union Medical Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300121, China.
Zhen YangTianjin Institute of Coloproctology, Tianjin Union Medical Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300121, China.
Jie HaoTianjin Institute of Coloproctology, Tianjin Union Medical Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300121, China.
Zhansheng JiangTianjin Institute of Coloproctology, Tianjin Union Medical Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300121, China. zhjiang@tmu.edu.cn.
Ming GaoTianjin Institute of Coloproctology, Tianjin Union Medical Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300121, China. headandneck2008@126.com.
Xipeng ZhangTianjin Institute of Coloproctology, Tianjin Union Medical Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300121, China. zhxp1011@163.com.
Mingqing ZhangTianjin Institute of Coloproctology, Tianjin Union Medical Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300121, China. zmq@nankai.edu.cn.

Funding

National Natural Science Foundation of China 82173125Tianjin Key Medical Discipline (Specialty) Construction Project TJYXZDXK-044ATianjin Key Medical Discipline (Specialty) Construction Project TJYXZDXK-058B
6 · The paper itself

Abstract

Microplastics are ubiquitous environmental contaminants worldwide. Although studies have shown their potential to harm human health, the relationship between microplastics and tumors remains unclear. The intestine is the primary site for microplastics absorption, thus the impact of microplastics on colorectal cancer merits further investigation. Our results indicate that the endocytosis protein clathrin, highly expressed in cancer cells, plays a crucial role in the massive ingestion of microplastics. Further research reveals that microplastics ingestion enhances lipid absorption in colorectal cancer cells by activating the NF-κB signaling pathway. Accumulation of lipids, in turn, suppresses pyroptosis by inhibiting NLRP3/Caspase-1/GSDMD axis, thereby promoting cellular drug resistance. Moreover, microplastics accelerate colorectal cancer development in mice and enhance tumor resistance to oxaliplatin. In summary, microplastics regulate lipid metabolism and pyroptosis in colorectal cancer, emerging as a novel contributor to chemotherapy resistance in colorectal cancer against the backdrop of escalating microplastics pollution.

Indexed as

Colorectal NeoplasmsDrug Resistance, NeoplasmLipid MetabolismMicroplasticsPyroptosisAnimalsCaspase 1Cell Line, TumorHumansMiceNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinOxaliplatinSignal TransductionCaspase 1MicroplasticsNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinOxaliplatinChemo-resistanceColorectal cancerLipid accumulationMicroplasticsPyroptosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.